Acadia Healthcare Company, Inc. current report, 04 February 2016

Business Context and Reporting Period

This Form 8-K was filed by Acadia Healthcare Company, Inc. on February 5, 2016, reporting events occurring on February 4, 2016. The filing details the entry into a material definitive agreement regarding a new debt offering.

Key Financial Metrics and Transaction Details

  • Debt Issuance: The Company agreed to sell $390 million in aggregate principal amount of 6.500% senior notes due 2024.
  • Underwriters: Merrill Lynch, Pierce, Fenner & Smith Incorporated and Jefferies LLC served as representatives of the initial purchasers.
  • Use of Proceeds: Funds are designated to finance a portion of the purchase price for the planned acquisition of Priory Group No. 1 Limited ("Priory") and related transaction fees and expenses.
  • Closing Conditions: The offering is conditioned upon and will occur concurrently with the closing of the Priory acquisition, expected on February 16, 2016.

The filing text does not provide clear values for current revenue, profit, cash flow, operating margins, or existing liquidity positions.

Material Changes

The primary material change is the expansion of the Company's capital structure through the issuance of $390 million in senior notes. This transaction represents a significant increase in long-term debt obligations to facilitate a strategic acquisition.

Outlook, Risks, and Contingencies

  • Acquisition Contingency: The success of the debt offering is directly contingent on the closing of the Priory Group acquisition.
  • Regulatory Framework: The offering is structured as a private placement to qualified institutional buyers under Rule 144A and to non-U.S. persons under Regulation S.
  • Management Commentary: The filing references a press release issued on February 4, 2016, regarding the pricing of the notes, but does not include detailed management commentary within the text provided.

Key Facts for Investor Verification

  • Verify the final closing date of the Priory Group acquisition to confirm the debt issuance proceeds as scheduled.
  • Review the full Purchase Agreement (Exhibit 10) for specific covenants, repayment terms, and default provisions associated with the 6.500% senior notes.
  • Confirm the total purchase price of the Priory acquisition to assess the proportion of funding covered by this $390 million note issuance versus other capital sources.
  • Monitor the Company's subsequent filings for the impact of the new debt on leverage ratios and interest coverage.